JRF103 / Jinrui Foundation - LARVOL DELTA

An ultra-performance LC-MS/MS method for determination of JRF103 in human plasma: application in first-in-patient study. (PubMed, Bioanalysis) - "The developed method was fully validated following the international guides. The developed method was sensitive, specific and suitable for measuring JRF103 concentration in patients with advanced solid tumors in the first-in-patient study of JRF103."

Journal • Oncology • Solid Tumor • EGFR • ERBB4 • HER-2